Wound healing can be improved by (—)‐epigallocatechin gallate through targeting Notch in streptozotocin‐induced diabetic mice

Wiley - Tập 33 Số 1 - Trang 953-964 - 2019
Yewei Huang1,2,3, Qiangqiang Zhu4,2,3, Xiaoying Yang4,2, Huanhuan Xu4,2, Bin Sun4,2, Xuanjun Wang1,2,5, Jun Sheng2,5
1College of Science, Yunnan Agricultural University, Kunming, China
2Key Laboratory of Pu-erh Tea Science, Ministry of Education, Yunnan Agricultural University, Kunming, China
3these authors contributed equally to this work
4College of Food Science and Technology, Yunnan Agricultural University, Kunming, China
5State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, Kunming, China

Tóm tắt

ABSTRACTDelayed wound healing is one of the most prominent clinical manifestations of diabetes and lacks satisfactory treatment options. Persistent inflammation occurs in the late phase of wound healing and impairs the healing process in mice with diabetes mellitus (DM). In this study, we observed that the late wound healing in streptozotocin (STZ)‐induced DM mice could be improved by (−)‐epigallocatechin gallate (EGCG). The macrophage accumulation, inflammation response, and Notch signaling can be inhibited by EGCG in the skin wounds of DM mice. Furthermore, we found that the LPS‐induced inflammation response including overactivated Notch signaling, was inhibited by EGCG in mouse macrophages. Moreover, we confirmed that EGCG could directly bind with mouse Notch‐1. In addition, our studies indicated that diabetic wound healing was improved by EGCG treatment before or after the inflammation phase by targeting the Notch signaling pathway, which suggests that the pre‐existing diabetic wound healing can be improved by EGCG. To summarize, wound healing can be improved by EGCG through targeting Notch in STZ‐induced DM mice. Our findings provide insight into the therapeutic strategy for diabetic wounds and offer EGCG as a novel potential medicine to treat chronic wounds.—Huang, Y.‐W., Zhu,Q.‐Q., Yang,X.‐Y., Xu,H.‐H., Sun,B., Wang,X.‐J., Sheng,J.Wound healing can be improved by (−)‐epigallocatechin gallate through targeting Notch in streptozotocin‐induced diabetic mice. FASEB J. 33, 953–964 (2019). www.fasebj.org

Từ khóa


Tài liệu tham khảo

10.1172/JCI32169

10.1038/ncomms13393

10.1097/01.prs.0000225470.42514.8f

10.3389/fimmu.2017.00635

10.1016/S0140-6736(03)13169-8

10.1111/j.1464-5491.2008.02573.x

Centers for Disease Control and Prevention (CDC), 2011, Self-reported visual impairment among persons with diagnosed diabetes: United States, 1997–2010, MMWR Morb. Mortal. Wkly. Rep., 60, 1549

10.3390/ijms18051068

10.1007/s12325-014-0140-x

10.1242/dmm.012237

10.1017/S1462399411001943

10.1016/j.imbio.2011.01.001

10.4049/jimmunol.1700223

10.1182/blood-2010-12-327015

Outtz H. H., 2011, Notch regulates macrophage function during inflammation and angiogenesis

Sunkari V., 2012, New pathogenic mechanisms in diabetic wound healing

10.1080/13543776.2016.1203419

Wang T., 2017, (−)-Epigallocatechin gallate targets notch to attenuate the inflammatory response in the immediate early stage in human macrophages, Front. Immunol., 8, 433

10.1038/laban0209-55

10.1042/BSR20171294

10.1248/bpb.23.1458

10.2337/db12-1450

10.2337/db14-0872

10.1007/s00018-016-2268-0

10.1111/j.1365-2249.2006.03229.x

10.1007/s11892-013-0375-y

10.1002/eji.200636999

10.1111/j.1524-475X.2009.00543.x

10.2337/db13-0927

10.1016/j.ajpath.2010.08.003

10.1083/jcb.200611015

10.1046/j.1524-475x.2000.00013.x

10.1046/j.1523-1747.2000.00029.x

10.4049/jimmunol.0904016

10.4049/jimmunol.0903356

10.3109/07853890.2010.495951